About PolpharmaWe are the largest Polish manufacturer of pharmaceuticals and a leader of the Polish pharmaceutical market. We actively operate in the markets of Central and Eastern Europe, the Caucasus and Central Asia.
ResponsibilityBeing the largest Polish pharmaceutical company we want to help people to live a healthy life in a healthy world. Social responsibility is an integral part of the management strategy in our company.
CareerPolpharma's development is possible only thanks to the commitment of our employees as well as the involvement of students and graduates in various business areas.
PRICE INQUIRY No. SEMA/64A/PR116034/2025 – being conducted as a market assessment study 18 July 2025In connection with the implementation of the project titled “Development and advancement of an innovative solution – a generic drug from the group of GLP-1… read more
Other PRICE INQUIRY No. NUSI/124/PR113373/2025 – being conducted as a market assessment study 18 June 2025In connection with the implementation of the project titled “Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and epidemiological… read more
PRICE INQUIRY No. SEMA/63/PR108349/2025 – being conducted as a market assessment study13 June 2025In connection with the implementation of the project titled “Design and development of an innovative solution – a drug from the group of GLP-1 receptor… read more
Company News Markus Sieger takes the helm as President ad interim at Medicines for Europe12 June 2025Markus’ previous experience in Medicines for Europe spans the range of priority topics for our sector, including the EU pharmaceutical legislation, Critical Medicines Act, the… read more
Company News Other Polpharma Group Supports Urgent EU Action to Safeguard Access to Medicines and Strengthen European Pharmaceutical Sovereignty04 June 2025The letter, signed by CEOs and senior executives from across the European off-patent medicines sector, focuses on the need to: Accelerate the adoption of the… read more
